A detailed history of Pnc Financial Services Group, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 656,766 shares of EW stock, worth $43 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
656,766
Previous 666,642 1.48%
Holding current value
$43 Million
Previous $63.7 Million 4.77%
% of portfolio
0.04%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$84.3 - $94.31 $832,546 - $931,405
-9,876 Reduced 1.48%
656,766 $60.7 Million
Q1 2024

May 10, 2024

SELL
$72.54 - $95.56 $769,576 - $1.01 Million
-10,609 Reduced 1.57%
666,642 $63.7 Million
Q4 2023

Feb 09, 2024

SELL
$61.71 - $77.76 $2.76 Million - $3.48 Million
-44,738 Reduced 6.2%
677,251 $51.6 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $2.08 Million - $2.8 Million
-30,015 Reduced 3.99%
721,989 $50 Million
Q2 2023

Aug 11, 2023

SELL
$81.41 - $94.33 $2.34 Million - $2.71 Million
-28,724 Reduced 3.68%
752,004 $70.9 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $15,446 - $17,578
-208 Reduced 0.03%
780,728 $64.6 Million
Q4 2022

Feb 10, 2023

SELL
$68.3 - $87.44 $945,476 - $1.21 Million
-13,843 Reduced 1.74%
780,936 $58.3 Million
Q3 2022

Nov 10, 2022

SELL
$82.37 - $107.29 $1.72 Million - $2.25 Million
-20,942 Reduced 2.57%
794,779 $65.7 Million
Q2 2022

Aug 12, 2022

SELL
$86.5 - $128.27 $2.91 Million - $4.31 Million
-33,614 Reduced 3.96%
815,721 $77.6 Million
Q1 2022

May 12, 2022

SELL
$101.96 - $128.34 $1.34 Million - $1.68 Million
-13,099 Reduced 1.52%
849,335 $100 Million
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $1.09 Million - $1.34 Million
-10,236 Reduced 1.17%
862,434 $112 Million
Q3 2021

Nov 05, 2021

SELL
$102.91 - $122.75 $567,857 - $677,334
-5,518 Reduced 0.63%
872,670 $98.8 Million
Q2 2021

Aug 06, 2021

SELL
$83.84 - $104.76 $2.15 Million - $2.69 Million
-25,676 Reduced 2.84%
878,188 $91 Million
Q1 2021

May 07, 2021

SELL
$78.68 - $90.67 $41.5 Million - $47.8 Million
-527,268 Reduced 36.84%
903,864 $75.6 Million
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $658,831 - $838,403
-9,190 Reduced 0.64%
1,431,132 $131 Million
Q3 2020

Nov 06, 2020

SELL
$67.19 - $87.44 $1.04 Million - $1.35 Million
-15,484 Reduced 1.06%
1,440,322 $115 Million
Q2 2020

Aug 07, 2020

BUY
$57.54 - $76.95 $54.4 Million - $72.8 Million
946,157 Added 185.65%
1,455,806 $101 Million
Q1 2020

May 08, 2020

SELL
$52.41 - $81.0 $703,394 - $1.09 Million
-13,421 Reduced 2.57%
509,649 $32 Million
Q4 2019

Feb 07, 2020

SELL
$71.7 - $82.09 $868,287 - $994,109
-12,110 Reduced 2.26%
523,070 $40.7 Million
Q3 2019

Nov 08, 2019

BUY
$61.55 - $75.43 $11.1 Million - $13.6 Million
179,729 Added 50.56%
535,180 $39.2 Million
Q2 2019

Aug 09, 2019

SELL
$55.74 - $64.41 $589,896 - $681,651
-10,583 Reduced 2.89%
355,451 $0
Q1 2019

May 10, 2019

SELL
$47.89 - $64.05 $818,631 - $1.09 Million
-17,094 Reduced 4.46%
366,034 $0
Q4 2018

Feb 08, 2019

SELL
$46.41 - $56.94 $585,787 - $718,696
-12,622 Reduced 3.19%
383,128 $19.6 Million
Q3 2018

Nov 09, 2018

SELL
$45.7 - $58.03 $561,927 - $713,536
-12,296 Reduced 3.01%
395,750 $0
Q2 2018

Aug 10, 2018

SELL
$42.45 - $51.3 $1.58 Million - $1.91 Million
-37,278 Reduced 8.37%
408,046 $0
Q1 2018

May 11, 2018

SELL
$37.19 - $47.45 $2.67 Million - $3.41 Million
-71,911 Reduced 13.9%
445,324 $0
Q4 2017

Feb 09, 2018

SELL
$33.79 - $39.39 $23 Million - $26.8 Million
-679,509 Reduced 56.78%
517,235 $0
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $43.4 Million - $46.5 Million
1,196,744
1,196,744 $0

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.